Streetbeat News

Earnings

MRVI

Maravai LifeSciences (NASDAQ:MRVI) reported Q4 2023 adjusted EPS of $0.01, surpassing the $(0.01) estimate, with sales of $74.14M beating the $64.38M estimate, a 63.78% decrease from last year's $204.71M.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 9:11 pm

BKNG

Booking Holdings Inc. shares are trading lower following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 9:10 pm

GH

Guardant Health (NASDAQ:GH) reported Q4 earnings with an EPS of $-0.64, beating estimates by 26.44% against an expected $-0.87. Revenue increased by $28.16 million from the same period last year. Despite beating last quarter's EPS estimate, the share price dropped by 5.41% the following day. The company has shown consistent improvement in both EPS and revenue over the past four quarters.

Portfolio Pulse from Benzinga Insights

February 22, 2024 | 9:10 pm

SFM

Sprouts Farmers Market (NASDAQ:SFM) reported Q4 earnings, beating estimates with an EPS of $0.49 against the expected $0.45, an 8.89% increase. Revenue rose by $122.45 million year-over-year. Despite beating last quarter's EPS estimate, SFM's share price dropped by 3.45% the following day. Historical earnings data shows a pattern of surpassing EPS estimates.

Portfolio Pulse from Benzinga Insights

February 22, 2024 | 9:10 pm

BCOV

Brightcove (NASDAQ:BCOV) reported Q4 earnings with a 300% beat on estimated EPS, reporting $0.04 vs. an estimate of $0.01. Revenue increased by $918k from the same period last year. Despite beating last quarter's EPS estimate, the share price dropped by 8.1% the next day. The company has had varied performance over the past quarters, with both beats and misses on EPS and revenue estimates.

Portfolio Pulse from Benzinga Insights

February 22, 2024 | 9:10 pm

SPXC

SPX Techs (NYSE:SPXC) reported Q4 2023 adjusted EPS of $1.25, missing the $1.26 estimate, and sales of $469.40M, missing the $481.94M estimate. This represents a 9.34% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 9:10 pm

EIX

Edison Intl (NYSE:EIX) reported Q4 earnings with an EPS of $1.28, beating estimates by 10.34% but with a revenue decrease of $310 million from the previous year. The company had previously missed EPS estimates last quarter, leading to a slight share price drop. The report details a mixed performance over the past year, with varying success in meeting EPS and revenue estimates.

Portfolio Pulse from Benzinga Insights

February 22, 2024 | 9:10 pm

VIR

Vir Biotechnology (NASDAQ:VIR) reported Q4 earnings with an EPS of $-0.86, beating estimates by 14.85% but with a revenue decrease of $32.62 million from the previous year. Despite missing EPS estimates last quarter, the share price increased by 6.96% the following day.

Portfolio Pulse from Benzinga Insights

February 22, 2024 | 9:10 pm

DAIO

Data I/O (NASDAQ:DAIO) reported Q4 2023 GAAP EPS of $0.02 and sales of $6.87M, surpassing the $6.79M estimate. This represents a 5.46% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 9:09 pm

GH

Guardant Health (NASDAQ:GH) reported Q4 adjusted EPS of $(0.64), surpassing the $(0.87) estimate, and sales of $155.05M, exceeding the $149.57M estimate. This represents a 45.3% decrease in losses per share and a 22.19% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 9:09 pm